Swipe om te navigeren naar een ander artikel
To pilot the newly developed Idio Scale Judgment method for estimating the amount of score change that matters to patients (i.e., change thresholds).
An online panel of 500 participants diagnosed with multiple sclerosis (MS) responded to the Neuro-QoL fatigue scale and to demographic and clinical questions. Participants compared their own fatigue to that represented by seven short form summaries (SFSs) that were located relatively close to their own fatigue levels. They judged these as representing the same, greater, or less fatigue than their own. We calculated the distances between patients’ own levels of fatigue and the location of SFSs they endorsed as a change that would make a difference in daily life. These distances were used as estimates of change thresholds. Logically inconsistent judgments were tabulated and associations with clinical and demographic variables were estimated.
Change thresholds based on mean individual thresholds for consequential change were calculated for improvement (−3.5) and worsening (3.2). The majority of participants had no logically inconsistent judgments (69%). Having one or more reversals in judgment was not significantly associated with education or fatigue score, but was weakly associated with age, gender, and MS type and moderately associated with ratings of confidence in SFS comparisons.
As piloted, Idio Scale Judgment had a number of design strengths. Participants made comparisons to levels of fatigue that were within range of their own, and their judgments were contextualized in personally relevant consequences. The design lends itself to collection of data in large samples allowing evaluation of the range of judgments. Some study limitations could be mitigated with modifications. We concluded that the Idio Scale Judgment has substantial promise as a new tool for estimating change thresholds.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
What is comparative effectiveness research. https://effectivehealthcare.ahrq.gov/index.cfm/what-is-comparative-effectiveness-research1/
Khullar, O. V., Rajaei, M. H., Force, S. D., Binongo, J. N., Lasanajak, Y., Robertson, S., Pickens, A., Sancheti, M. S., Lipscomb, J., Gillespie, T. W., Fernandez, F. G. (2017). Pilot study to integrate patient reported outcomes after lung cancer operations into the Society of Thoracic Surgeons Database. The Annals of Thoracic Surgery.
Betts, K. A., Griffith, J., Friedman, A., Zhou, Z. Y., Signorovitch, J. E., & Ganguli, A. (2016). An indirect comparison and cost per responder analysis of adalimumab, methotrexate and apremilast in the treatment of methotrexate-naive patients with psoriatic arthritis. Current Medical Research and Opinion, 32, 721–729. CrossRefPubMed
Brasure, M., Fuchs, E., MacDonald, R., Nelson, V. A., Koffel, E., Olson, C. M., et al. (2016). Psychological and behavioral interventions for managing insomnia disorder: An evidence report for a Clinical Practice Guideline by the American College of Physicians. Annals of Internal Medicine, 165, 113–124. CrossRefPubMed
US Department of Health and Human Services FDA Center for Drug Evaluation and Research, US Department of Health and Human Services FDA Center for Biologics Evaluation and Research, & US Department of Health and Human Services FDA Center for Devices and Radiological Health. (2006). Guidance for industry: Patient-reported outcome measures: use in medical product development to support labeling claims: Draft guidance. Health Qual Life Outcomes 4, 79.
Uryniak, T. C. I., Fedorov, V. V., Jiang, Q., Oppenheimer, L., Stapinn, S., Teng, C.-H., et al. (2011). Responder analyses: A PhRMA position paper. Statistics in Biopharmaceutical Research, 3, 476–487. CrossRef
Coon, C. D., Cook, K. F. (2016). Telling the interpretation story: the case for strong anchors and multiple methods. In Plenary presentation at the 23rd Annual Conference of the International Society of Quality for Life Research.
Ross, M. (1989). Relation of implicit theories to the construction of personal histories. Psychological Review, 96, 341–357. CrossRef
Kamper, S. J., Ostelo, R. W., Knol, D. L., Maher, C. G., de Vet, H. C., & Hancock, M. J. (2010). Global perceived effect scales provided reliable assessments of health transition in people with musculoskeletal disorders, but ratings are strongly influenced by current status. Journal of Clinical Epidemiology, 63, 760–766. CrossRefPubMed
Gershon, R. C., Lai, J. S., Bode, R., Choi, S., Moy, C., Bleck, T., et al. (2012). Neuro-QOL: Quality of life item banks for adults with neurological disorders: Item development and calibrations based upon clinical and general population testing. Quality of Life Research, 21, 475–486. CrossRefPubMed
HealthMeasures.net. (2016). Quality of life in neurological disorders: Scoring manual.
- Idio Scale Judgment: evaluation of a new method for estimating responder thresholds
Karon F. Cook
Michael A. Kallen
Cheryl D. Coon
Deborah M. Miller
- Springer International Publishing